Search
for
Sort by
Research 391–420 of 1000+
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Is seborrhea a sign of autonomic impairment in Parkinson's disease?
- Endocrine-skin interactions
- Skin manifestations of obesity: a comparative study
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Acne in the adult female patient: a practical approach
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Evidence-based approach to cutaneous hyperandrogenism in women
- Mood disorders and quality of life in polycystic ovary syndrome
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Hirsutism: Diagnosis and management
- Androgens and Antiandrogens
- Pseudoacromegaly induced by the long-term use of minoxidil
- Polycystic ovary syndrome (PCOS)
- Diet in dermatology: Revisited
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Post‐COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Studying the genetic predisposing factors in the pathogenesis of acne vulgaris
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Current evaluation of amenorrhea
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?